- Approval Id
- 6f6773e1ef3c17a0
- Drug Approval Emc Name
- Corsodyl Spray
- Drug Name
- Corsodyl Spray
- Company Name
- Haleon UK Trading Limited
- Company Address
- The Heights, Weybridge, Surrey, KT13 0NY, UK
- Company Website
- https://www.haleon.com/
- Company Medical Info Direct Line
- 0800 783 8881
- Company Medical Info Email
- mystory.gb@haleon.com
- Company Customer Care Direct Line
- 0800 783 8881
- Legal Category
- General Sales List
- Authorisation Holder
- GlaxoSmithKline Consumer Healthcare (UK) Trading Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
- Authorisation Number
- PL 44673/0058
- Authorisation Date
- 10 February 1994 / 09 September 2008
- Instruction Authorisation Holder
- GlaxoSmithKline Consumer Healthcare (UK) Trading Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
- Instruction Authorisation Number
- PL 44673/0058
- Instruction Authorisation Date
- 10 February 1994 / 09 September 2008
- Instruction Composition
- Chlorhexidine Digluconate 0.2% w/v
(equivalent to Chlorhexidine Digluconate Solution Ph. Eur. 1.0% v/v)
Excipients: Contains Macrogolglycerol hydroxystearate 0.8% w/v
For a full list of excipients, see section 6.1.
- Instruction Dosage Form
- Oromucosal spray
- Instruction Clinical Particulars
- 4.1 Therapeutic indications
For inhibition of the formation of dental plaque.
As an aid in the treatment and prevention of gingivitis and in the maintenance of oral hygiene, particularly in situations where tooth brushing cannot be adequately employed (e.g. following oral surgery, in physically or mentally handicapped patients, the terminally ill or immunocompromised patients).
Also for use in a post-peridontal surgery or treatment\\* regimen to promote gingival healing.
\\*NB: Use as part of a post-periodontal treatment regimen has only been adequately studied over the short term and following standard root surface instrumentation.
It is useful in the management of aphthous ulceration and oral candidal infections (e.g. denture stomatitis and thrush).4.2 Posology and method of administration
\*\*Adults:\*\*
Corsodyl spray should be applied as required to the tooth and gingival surfaces, ulcers or other sore areas, using up to a maximum of twelve actuations of the spray (0.14 ml/actuation) twice daily. The spray should be applied once in the morning and once in the evening.
For the treatment of gingivitis a course of about one month is advisable although some variation in response is to be expected. In the case of aphthous ulceration and oral candidal infections treatment should be continued for 48 hours after clinical resolution.
For the treatment of dental stomatitis the dentures should be cleaned and then sprayed with Corsodyl spray.
Do not exceed the stated dose.
\*\*Children and the Elderly:\*\*
The normal adult dose is appropriate for elderly patients and children of 12 years and over unless otherwise recommended by the dentist or the physician.
Children under 12 years of age should not use the product unless recommended by a healthcare professional.
\*\*Route of administration:\*\*
External (oral) use only.4.3 Contraindications
Corsodyl is contraindicated for patients who have previously shown a hypersensitivity reaction to Chlorhexidine or to any of the excipients in the formulation.4.4 Special warnings and precautions for use
For oral (external) use only. Do not swallow. Keep out of the eyes and ears.
If the spray comes into contact with the eyes, wash out promptly and thoroughly with water.
In case of soreness, swelling or irritation of the mouth, stop using the product and consult a healthcare professional.
Corsodyl is incompatible with anionic agents which are usually present in conventional dentifrices. These should therefore be used before Corsodyl (rinsing the mouth between applications) or at a different time of day.
In case of, swelling, or difficulty breathing stop using the product and seek immediate medical help. Transient disturbances of taste sensation and a numbness, tingling or burning sensation of the tongue may occur on initial use of the spray. These effects usually diminish with continued use. If the condition persists, consult a healthcare professional.
Discoloration of the teeth and tongue may occur. The stain is not permanent and can largely be prevented by reducing the consumption of dietary chromagens such as tea, coffee or red wine. In the case of dentures this can be prevented by cleaning with a conventional denture cleaner. In certain cases professional treatment (scaling and polishing) may be required to remove the stain completely. Stained anterior tooth- coloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement. Similarly where normal toothbrushing is not possible, for example with intermaxillary fixation, or with extensive orthodontic appliances, scaling and polishing may also be required once the underlying condition has been resolved.
Macrogolgylcerol hydroxystearate may cause skin reactions4.5 Interaction with other medicinal products and other forms of interaction
Chlorhexidine is incompatible with anionic agents.4.6 Fertility, pregnancy and lactation
There is no evidence of any adverse effects on the foetus arising from the use of Corsodyl during pregnancy or on infants during lactation. Therefore no special precautions are recommended.4.7 Effects on ability to drive and use machines
None have been reported or are known.4.8 Undesirable effects
Adverse events are listed below by system organ class and frequency. Frequencies are defined as: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100); rare (≥1/10,000 to <1/1000); and very rare (<1/10,000). The data from clinical trials are estimates. Post-marketing data refer to reporting rate rather than true frequency.
\*\*\*Clinical Trial Data\*\*\*
| | |
| --- | --- |
| \*\*Gastrointestinal Disorders\*\* | |
| Very Common: | Tongue coated |
| Common: | Dry mouth |
| \*\*Nervous system disorders\*\* | |
| Common: | Aguesia / dysguesia Glossodynia Oral paraesthesia / hypoaesthesia |
\*\*\*Post Marketing Data\*\*\*
| | |
| --- | --- |
| \*\*Gastrointestinal Disorders\*\* | |
| Isolated reports: | Discoloration of the teeth and tongue (see section 4.4) Irritation of the mouth (see section 4.4) Desquamation / swelling of oral mucosa (see section 4.4) Parotid gland swelling |
| \*\*Immune System Disorders\*\* | |
| Isolated reports: | Hypersensitivity and anaphylaxis (see section 4.3 and 4.4) |
Undesirable effects are generally minor and local in nature.
\*\*Reporting of suspected adverse reactions\*\*
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. or search for MHRA Yellow Card in the Google Play or Apple App Store.4.9 Overdose
Chlorhexidine taken orally is poorly absorbed. Although systemic effects are unlikely even if large volumes are ingested, seek medical advice for appropriate action.
Due to the alcohol content (7.0 % v/v) ingestion of large amounts by children requires attention. Seek medical advice for appropriate action.
- Instruction Pharmacology
- 5.1 Pharmacodynamic properties
Corsodyl Spray contains 0.2% w/v chlorhexidine digluconate which is an antimicrobial preparation for external use. It is effective against a wide range of Gram negative and Gram positive vegetative bacteria, yeasts, dermatophyte fungi and lipophilic viruses. It is active against a wide range of important oral pathogens and is therefore effective in the treatment of many common dental conditions.5.2 Pharmacokinetic properties
Because of its cationic nature, chlorhexidine binds strongly to skin, mucosa and tissues and is thus very poorly absorbed. No detectable blood levels have been found following oral use.5.3 Preclinical safety data
No information further to that contained in other sections of the SPC is included.
- Instruction Pharmaceutical Particulars
- 6.1 List of excipients
Ethanol,
Macrogolglycerol Hydroxystearate,
Sorbitol 70 per cent (non-crystallising),
Peppermint oil,
Purified water.6.2 Incompatibilities
Hypochlorite bleaches may cause brown stains to develop in fabrics that have previously been in contact with preparations containing chlorhexidine.6.3 Shelf life
Three years.6.4 Special precautions for storage
Store below 25°C, protect from light.6.5 Nature and contents of container
A clear sodaglass bottle, externally coated with opaque white polyvinylchloride (PVC) of nominal capacity 75 ml. The closure is a polypropylene, polyethylene, stainless steel pump dispenser incorporating a seal made of polyether ketone (PEK) and mounted in an aluminium cap, which is manually actuated and non-removable. It can be fitted with a detachable polyethylene actuator/spray head.
Each bottle contains 60 ml.6.6 Special precautions for disposal and other handling
None.
- Instruction Content
- ## Composition
Chlorhexidine Digluconate 0.2% w/v
(equivalent to Chlorhexidine Digluconate Solution Ph. Eur. 1.0% v/v)
Excipients: Contains Macrogolglycerol hydroxystearate 0.8% w/v
For a full list of excipients, see section 6.1.
## Pharmaceutical Form
Oromucosal spray
## Clinical Particulars
4.1 Therapeutic indications
For inhibition of the formation of dental plaque.
As an aid in the treatment and prevention of gingivitis and in the maintenance of oral hygiene, particularly in situations where tooth brushing cannot be adequately employed (e.g. following oral surgery, in physically or mentally handicapped patients, the terminally ill or immunocompromised patients).
Also for use in a post-peridontal surgery or treatment\\* regimen to promote gingival healing.
\\*NB: Use as part of a post-periodontal treatment regimen has only been adequately studied over the short term and following standard root surface instrumentation.
It is useful in the management of aphthous ulceration and oral candidal infections (e.g. denture stomatitis and thrush).4.2 Posology and method of administration
\*\*Adults:\*\*
Corsodyl spray should be applied as required to the tooth and gingival surfaces, ulcers or other sore areas, using up to a maximum of twelve actuations of the spray (0.14 ml/actuation) twice daily. The spray should be applied once in the morning and once in the evening.
For the treatment of gingivitis a course of about one month is advisable although some variation in response is to be expected. In the case of aphthous ulceration and oral candidal infections treatment should be continued for 48 hours after clinical resolution.
For the treatment of dental stomatitis the dentures should be cleaned and then sprayed with Corsodyl spray.
Do not exceed the stated dose.
\*\*Children and the Elderly:\*\*
The normal adult dose is appropriate for elderly patients and children of 12 years and over unless otherwise recommended by the dentist or the physician.
Children under 12 years of age should not use the product unless recommended by a healthcare professional.
\*\*Route of administration:\*\*
External (oral) use only.4.3 Contraindications
Corsodyl is contraindicated for patients who have previously shown a hypersensitivity reaction to Chlorhexidine or to any of the excipients in the formulation.4.4 Special warnings and precautions for use
For oral (external) use only. Do not swallow. Keep out of the eyes and ears.
If the spray comes into contact with the eyes, wash out promptly and thoroughly with water.
In case of soreness, swelling or irritation of the mouth, stop using the product and consult a healthcare professional.
Corsodyl is incompatible with anionic agents which are usually present in conventional dentifrices. These should therefore be used before Corsodyl (rinsing the mouth between applications) or at a different time of day.
In case of, swelling, or difficulty breathing stop using the product and seek immediate medical help. Transient disturbances of taste sensation and a numbness, tingling or burning sensation of the tongue may occur on initial use of the spray. These effects usually diminish with continued use. If the condition persists, consult a healthcare professional.
Discoloration of the teeth and tongue may occur. The stain is not permanent and can largely be prevented by reducing the consumption of dietary chromagens such as tea, coffee or red wine. In the case of dentures this can be prevented by cleaning with a conventional denture cleaner. In certain cases professional treatment (scaling and polishing) may be required to remove the stain completely. Stained anterior tooth- coloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement. Similarly where normal toothbrushing is not possible, for example with intermaxillary fixation, or with extensive orthodontic appliances, scaling and polishing may also be required once the underlying condition has been resolved.
Macrogolgylcerol hydroxystearate may cause skin reactions4.5 Interaction with other medicinal products and other forms of interaction
Chlorhexidine is incompatible with anionic agents.4.6 Fertility, pregnancy and lactation
There is no evidence of any adverse effects on the foetus arising from the use of Corsodyl during pregnancy or on infants during lactation. Therefore no special precautions are recommended.4.7 Effects on ability to drive and use machines
None have been reported or are known.4.8 Undesirable effects
Adverse events are listed below by system organ class and frequency. Frequencies are defined as: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1000 to <1/100); rare (≥1/10,000 to <1/1000); and very rare (<1/10,000). The data from clinical trials are estimates. Post-marketing data refer to reporting rate rather than true frequency.
\*\*\*Clinical Trial Data\*\*\*
| | |
| --- | --- |
| \*\*Gastrointestinal Disorders\*\* | |
| Very Common: | Tongue coated |
| Common: | Dry mouth |
| \*\*Nervous system disorders\*\* | |
| Common: | Aguesia / dysguesia Glossodynia Oral paraesthesia / hypoaesthesia |
\*\*\*Post Marketing Data\*\*\*
| | |
| --- | --- |
| \*\*Gastrointestinal Disorders\*\* | |
| Isolated reports: | Discoloration of the teeth and tongue (see section 4.4) Irritation of the mouth (see section 4.4) Desquamation / swelling of oral mucosa (see section 4.4) Parotid gland swelling |
| \*\*Immune System Disorders\*\* | |
| Isolated reports: | Hypersensitivity and anaphylaxis (see section 4.3 and 4.4) |
Undesirable effects are generally minor and local in nature.
\*\*Reporting of suspected adverse reactions\*\*
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. or search for MHRA Yellow Card in the Google Play or Apple App Store.4.9 Overdose
Chlorhexidine taken orally is poorly absorbed. Although systemic effects are unlikely even if large volumes are ingested, seek medical advice for appropriate action.
Due to the alcohol content (7.0 % v/v) ingestion of large amounts by children requires attention. Seek medical advice for appropriate action.
## Pharmacological Properties
5.1 Pharmacodynamic properties
Corsodyl Spray contains 0.2% w/v chlorhexidine digluconate which is an antimicrobial preparation for external use. It is effective against a wide range of Gram negative and Gram positive vegetative bacteria, yeasts, dermatophyte fungi and lipophilic viruses. It is active against a wide range of important oral pathogens and is therefore effective in the treatment of many common dental conditions.5.2 Pharmacokinetic properties
Because of its cationic nature, chlorhexidine binds strongly to skin, mucosa and tissues and is thus very poorly absorbed. No detectable blood levels have been found following oral use.5.3 Preclinical safety data
No information further to that contained in other sections of the SPC is included.
## Pharmaceutical Particulars
6.1 List of excipients
Ethanol,
Macrogolglycerol Hydroxystearate,
Sorbitol 70 per cent (non-crystallising),
Peppermint oil,
Purified water.6.2 Incompatibilities
Hypochlorite bleaches may cause brown stains to develop in fabrics that have previously been in contact with preparations containing chlorhexidine.6.3 Shelf life
Three years.6.4 Special precautions for storage
Store below 25°C, protect from light.6.5 Nature and contents of container
A clear sodaglass bottle, externally coated with opaque white polyvinylchloride (PVC) of nominal capacity 75 ml. The closure is a polypropylene, polyethylene, stainless steel pump dispenser incorporating a seal made of polyether ketone (PEK) and mounted in an aluminium cap, which is manually actuated and non-removable. It can be fitted with a detachable polyethylene actuator/spray head.
Each bottle contains 60 ml.6.6 Special precautions for disposal and other handling
None.
